KATHRYN F ZIEGLER
Allopathic & Osteopathic Physicians|Internal Medicine SPRING, TX NPI 1114111408
Browse related groups: Allopathic & Osteopathic Physicians|Internal Medicine TX Bayer HealthCare Pharmaceuticals Inc. All categories
General Payments — all program years on this page
$12,015.80
- Category: General Payments
- Program years: PY2018–2024
- Record count: 656
- As of (CMS publication): 2026-01-23
Latest program year (PY2024): $1,322.88 across 49 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2024) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $1,322.88 | 49 |
By paying entity
Latest program year (PY2024) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| Bayer HealthCare Pharmaceuticals Inc. | $309.10 | 5 |
| Amgen Inc. | $182.97 | 9 |
| Regeneron Healthcare Solutions, Inc. | $161.26 | 3 |
| Lilly USA, LLC | $141.25 | 10 |
| Medtronic, Inc. | $99.98 | 1 |
| PFIZER INC. | $91.49 | 4 |
| Sumitomo Pharma America, Inc. | $57.50 | 3 |
| Esperion Therapeutics, Inc. | $39.66 | 2 |
| Takeda Pharmaceuticals U.S.A., Inc. | $38.99 | 1 |
| Acerta Pharma LLC | $38.88 | 2 |
| Exact Sciences Corporation | $30.81 | 2 |
| Seqirus USA Inc | $28.44 | 1 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $20.33 | 1 |
| Azurity Pharmaceuticals, Inc. | $19.33 | 1 |
| Kowa Pharmaceuticals America, Inc. | $16.92 | 1 |
| GlaxoSmithKline, LLC. | $16.45 | 1 |
| Novo Nordisk AS | $15.56 | 1 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $13.96 | 1 |
By program year
Records — PY2024 (49)
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.